X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/19/2848954/0/en/Design-Therapeutics-Outlines-Progress-Across-GeneTAC-Platform-and-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/12/2844360/0/en/Design-Therapeutics-to-Webcast-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Comprehensive-Portfolio-Update.html
https://endpts.com/design-therapeutics-hints-at-strategic-realignment-replaces-ceo-karyopharm-co-founder-leads-atps-nereid/
https://www.globenewswire.com//news-release/2023/11/13/2779439/0/en/Design-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Plans-for-a-Comprehensive-Portfolio-Update-in-Early-2024.html
https://www.fiercebiotech.com/biotech/design-therapeutics-goes-back-drawing-board-causing-delay-and-steep-stock-drop
https://endpts.com/following-injection-side-effects-design-therapeutics-to-reformulate-friedreichs-ataxia-drug/
https://www.globenewswire.com/news-release/2023/08/14/2724994/0/en/Design-Therapeutics-Provides-Pipeline-Update-and-Reports-Second-Quarter-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/08/14/2724955/0/en/Design-Therapeutics-Reports-Initial-Results-from-Phase-1-Multiple-Ascending-Dose-Study-of-DT-216-for-the-Treatment-of-Friedrich-Ataxia.html
https://www.globenewswire.com/news-release/2023/05/31/2679170/0/en/Design-Therapeutics-to-Present-at-the-2023-Jefferies-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2023/05/09/2664930/0/en/Design-Therapeutics-Provides-Pipeline-Updates-and-Reports-First-Quarter-2023-Financial-Results.html
Market Place
Share 
